CNTX
Price
$1.09
Change
+$0.03 (+2.83%)
Updated
Dec 3 closing price
Capitalization
100.61M
111 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$2.46
Change
+$0.21 (+9.33%)
Updated
Dec 3 closing price
Capitalization
348.2M
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTX vs PROK

Header iconCNTX vs PROK Comparison
Open Charts CNTX vs PROKBanner chart's image
Context Therapeutics
Price$1.09
Change+$0.03 (+2.83%)
Volume$421.68K
Capitalization100.61M
ProKidney
Price$2.46
Change+$0.21 (+9.33%)
Volume$1.05M
Capitalization348.2M
CNTX vs PROK Comparison Chart in %
CNTX
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTX vs. PROK commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a StrongBuy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CNTX: $1.05 vs. PROK: $2.26)
Brand notoriety: CNTX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 175% vs. PROK: 40%
Market capitalization -- CNTX: $100.61M vs. PROK: $348.2M
CNTX [@Biotechnology] is valued at $100.61M. PROK’s [@Biotechnology] market capitalization is $348.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTX is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 1 TA indicator(s) are bullish while PROK’s TA Score has 4 bullish TA indicator(s).

  • CNTX’s TA Score: 1 bullish, 6 bearish.
  • PROK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PROK is a better buy in the short-term than CNTX.

Price Growth

CNTX (@Biotechnology) experienced а -5.80% price change this week, while PROK (@Biotechnology) price change was +7.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

CNTX is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($348M) has a higher market cap than CNTX($101M). PROK YTD gains are higher at: 33.728 vs. CNTX (0.476). CNTX has higher annual earnings (EBITDA): -38.29M vs. PROK (-157.52M). PROK has more cash in the bank: 295M vs. CNTX (83.5M). CNTX has less debt than PROK: CNTX (167K) vs PROK (4.42M). PROK has higher revenues than CNTX: PROK (527K) vs CNTX (0).
CNTXPROKCNTX / PROK
Capitalization101M348M29%
EBITDA-38.29M-157.52M24%
Gain YTD0.47633.7281%
P/E RatioN/AN/A-
Revenue0527K-
Total Cash83.5M295M28%
Total Debt167K4.42M4%
TECHNICAL ANALYSIS
Technical Analysis
CNTXPROK
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
89%
Bullish Trend 7 days ago
67%
Momentum
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
65%
MACD
ODDS (%)
N/A
Bearish Trend 7 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
87%
Bullish Trend 7 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
73%
Advances
ODDS (%)
Bullish Trend 25 days ago
88%
Bullish Trend 7 days ago
74%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 7 days ago
70%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CNTX
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BSEG0.01N/A
N/A
Big Screen Entertainment Group, Inc.
FNBT37.35N/A
N/A
FineMark Holdings, Inc.
IFLXF0.82N/A
N/A
Imaflex Inc
RPGRF124.45N/A
N/A
REA Group Ltd
SMSOF2.10N/A
N/A
SAMSONITE GROUP S A

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RLYB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
N/A
RLYB - PROK
45%
Loosely correlated
-0.25%
NRIX - PROK
39%
Loosely correlated
-3.31%
APGE - PROK
38%
Loosely correlated
+0.20%
KYMR - PROK
37%
Loosely correlated
-3.80%
ZYME - PROK
37%
Loosely correlated
-3.57%
More